BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19917676)

  • 1. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation.
    Sina C; Gavrilova O; Förster M; Till A; Derer S; Hildebrand F; Raabe B; Chalaris A; Scheller J; Rehmann A; Franke A; Ott S; Häsler R; Nikolaus S; Fölsch UR; Rose-John S; Jiang HP; Li J; Schreiber S; Rosenstiel P
    J Immunol; 2009 Dec; 183(11):7514-22. PubMed ID: 19917676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.
    Xu Y; Hunt NH; Bao S
    Cell Res; 2008 Dec; 18(12):1220-9. PubMed ID: 19030026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
    Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
    Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis.
    Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW
    J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.
    Obermeier F; Dunger N; Strauch UG; Hofmann C; Bleich A; Grunwald N; Hedrich HJ; Aschenbrenner E; Schlegelberger B; Rogler G; Schölmerich J; Falk W
    Gastroenterology; 2005 Sep; 129(3):913-27. PubMed ID: 16143131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferons have opposing effects during the emergence and recovery phases of colitis.
    Rauch I; Hainzl E; Rosebrock F; Heider S; Schwab C; Berry D; Stoiber D; Wagner M; Schleper C; Loy A; Urich T; Müller M; Strobl B; Kenner L; Decker T
    Eur J Immunol; 2014 Sep; 44(9):2749-60. PubMed ID: 24975266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP provides colonic protection against dextran sodium sulfate induced colitis.
    Azuma YT; Hagi K; Shintani N; Kuwamura M; Nakajima H; Hashimoto H; Baba A; Takeuchi T
    J Cell Physiol; 2008 Jul; 216(1):111-9. PubMed ID: 18205183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.
    Kim MH; Kang SG; Park JH; Yanagisawa M; Kim CH
    Gastroenterology; 2013 Aug; 145(2):396-406.e1-10. PubMed ID: 23665276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in inflammation following blockade of CD18 or CD29 adhesive pathways during the acute phase of a spirochetal-induced colitis in mice.
    Sacco RE; Hutto DL; Waters WR; Xiasong L; Kehrli ME; Zuckermann FA; Wannemuehler MJ
    Microb Pathog; 2000 Nov; 29(5):289-99. PubMed ID: 11031123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner.
    Wimmer N; Huber B; Wege AK; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
    Mol Immunol; 2012 Jun; 51(2):128-35. PubMed ID: 22437076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis.
    Ohkawara T; Mitsuyama K; Takeda H; Asaka M; Fujiyama Y; Nishihira J
    Scand J Gastroenterol; 2008; 43(12):1497-504. PubMed ID: 18663662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender dependent importance of IRAK-1 in dextran sulfate sodium induced colitis.
    Berglund M; Thomas JA; Fredin MF; Melgar S; Hörnquist EH; Hultgren OH
    Cell Immunol; 2009; 259(1):27-32. PubMed ID: 19540456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus.
    Ghia JE; Galeazzi F; Ford DC; Hogaboam CM; Vallance BA; Collins S
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G770-7. PubMed ID: 18202111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
    Hassani H; Lucas G; Rozell B; Ernfors P
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G550-6. PubMed ID: 15499082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
    Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
    Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation.
    Dass NB; John AK; Bassil AK; Crumbley CW; Shehee WR; Maurio FP; Moore GB; Taylor CM; Sanger GJ
    Neurogastroenterol Motil; 2007 Jan; 19(1):66-74. PubMed ID: 17187590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
    Hyun E; Andrade-Gordon P; Steinhoff M; Vergnolle N
    Gut; 2008 Sep; 57(9):1222-9. PubMed ID: 18460552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
    Mollinedo F; Gajate C; Morales AI; del Canto-Jañez E; Justies N; Collía F; Rivas JV; Modolell M; Iglesias A
    J Pharmacol Exp Ther; 2009 May; 329(2):439-49. PubMed ID: 19244550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.